Insife

What is the new EU AI regulation and how will it impact the PV industry? In April 2021, the European Commission proposed the first EU regulatory framework for AI in order to ensure the safe, secure and ethical development of AI systems. A wide-held criticism of this new legislature, is its complexity and lack of clarity. Critics argue that the definition of 'AI systems' is particularly vague, leading to uncertainties about its scope and application. For the PV industry, its impact will be far reaching. Medical devices have been agreed as high risk and they will need to comply with new requirements including a conformity assessment to prove that the AI system complies with the specified requirements, which include a risk management system and having continuous tracking measures in place during the whole lifecycle. Read more about it here https://lnkd.in/dVHGVJy2 or contact us today at hello@insife.com to learn how we can help you stay up to date with the latest regulatory changes. #AI #EUregulation #thedrugsafetyexperts 

Need a better way to manage PV regulatory intelligence? Join our webinar to hear more about GRIP, Insife's unique PV Regulatory Intelligence subscription service.    We screen 1,500+ sources of regulatory information in 160+ countries on a weekly basis, so that you don't have to. Furthermore, our PV SMEs analyse the data for PV relevance, giving you structured, ready to use 'reporting rules'. Webinar Agenda: - Short intro to Insife and HALOPV - Understanding the Regulatory Intelligence landscape: + Common challenges + Why is it so difficult to keep up? - What is GRIP? + GRIP service: understand the services we provide + GRIP technology (HALOPV): see a demo + GRIP networking: meet and collaborate with the GRIP community  - How does the process work? + Meet the team + How we find information and determine what’s relevant + What's in scope – content and territories  + What we provide to our clients + How often you get updates - How GRIP can benefit your organisation - Q&A Register today: https://lnkd.in/dpKF6QDk #insife #qinecsa #halopv #GRIP #regintell

Client Feature: Dr. med. Arne Sprünken, Senior Director and Head of Safety & Benefit Risk, Medicinal Specialities, Grünenthal Group Dr. Arne Sprünken’s career has taken him from completing his doctorate to leading roles in pharmacovigilance at Grünenthal, all driven by his steadfast commitment to patient care. He developed a passion for medicine that led him through medical school and eventually to Grünenthal, where he’s spent the past 16 years enhancing drug safety and patient well-being. His expertise now includes overseeing Grünenthal’s Safety & Benefit Risks team which is focused on Grünenthal’s clinical development projects. Since 2023, Arne has partnered with Insife to streamline Grünenthal’s risk management processes through the HALOPV platform. "Insife has provided a customer-oriented service with excellent project management, making it easy to align HALOPV with our processes rather than the other way around," he says. With modules for Risk Management already live and Signals in development, Arne’s commitment to patient safety is as strong as ever, now supported by innovative technology that enhances Grünenthal’s mission. Learn more about Dr. Arne Sprünken impressive career path and collaboration with Insife here https://lnkd.in/d-JyQ9gu #clientfeature #thedrugsafetyexperts

Shades anyone? It’s been a great day at WDSC US! #HALOPV #insife

Stop by and see us in Boston at booth 742 and pick up some HALOPV sunnies 😎 #HALOPV #insife

The World Drug Safety Congress Americas is buzzing with activity!! Today, Tuesday, October 29, 2024, at 11:30 AM, our CEO, Martin Holm-Petersen, will be speaking in room 051, on the topic “Future-proofing Pharmacovigilance: Governance, Data Collection, and Analyses for Global Success” Martin will be participating in Roundtable 08 on October 29 at 1:40 PM in Hall C. Come join the lively discussion! Martin is an executive leader with 10 years of experience within the pharma industry and another 10+ years in consulting. Martin is an experienced manager and strategist, with understanding across the pharma business value chain, and an expert on Pharmacovigilance. His current role is CEO of Insife, a global technology and consulting company. In this capacity, digital transformation is central to Martin’s engagements with Industry and Regulatory Agencies. Insife was founded in 2017 by CEO Martin Holm-Petersen when he realized that there were many operational systems in PV that could be vastly improved by an integrated system utilizing new and advancing technology. A year later, Insife launched HALOPV, a revolutionary platform that now manages all multi-vigilance processes within its 20 modules. The success of HALOPV has meant the company has grown exponentially over the last seven years. Visit us at booth 742 to learn how HALOPV can enhance your pharmacovigilance operations, or click the link to discover more https://lnkd.in/dEbDuKeX #thedrugsafetyexperts #WDSCAmericas #booth742 #insife #halopv 

With Diwali just around the corner, our team in India couldn’t wait to kick off the celebrations! The office recently came alive with vibrant attire, joyful moments, and a shared sense of togetherness. Known as the Festival of Lights, Diwali celebrates the triumph of light over darkness and good over evil, symbolizing hope, prosperity, and new beginnings. From a lively ramp walk to honoring our October birthdays, it was a day filled with color, laughter, and cheer. The energy was contagious, making it a memorable prelude to the official holiday. Wishing everyone a bright and joyous Diwali season ahead! #Diwali2024 #teaminsife #officecelebrations #workculture #festivaloflights

The World Drug Safety Congress Americas is less than a week away! Our team, including Martin Holm-Petersen (CEO), Jen Markey (Chief Sales and Marketing Officer), Wilfred Gilich (Vice President, US Operations) and Petra Dinghaus (Associate Director, Business Services), will be on-site to represent Insife and demonstrate our industry-leading pharmacovigilance platform, HALOPV. HALOPV is a game changing platform, with a unique subscription model, that will revolutionize your PV System with comprehensive and integrated modules for end-to-end Pharmacovigilance. Its new features will transform the way that companies can manage their PV processes and promises to create a unified ‘Integrated Universe’ that all pharma companies can enjoy, regardless of their size. For more information, visit us at Booth 742 during the WDSC Americas 2024. We look forward to seeing you! Book your time slot with us by contacting us on hello@insife.com! #thedrugsafetyexperts #WDSCamericas #booth742

Yesterday, our team Louise Tan, Global Head of Regulatory Intelligence, and Praveen Gupta, Vice President of Digital Innovation—attended the PV India Autumn Face-to-Face Forum, Navigating the Changing Regulatory and Technology Landscape, organized by Navitas Life Sciences. Louise delivered a presentation on The Global Regulatory Intelligence Club for Pharmacovigilance (GRIP) at 12:00 PM, followed by an engaging discussion titled Regulatory Intelligence for PV – What Does Good Look Like?. It was an insightful exchange of ideas and perspectives on the future of regulatory intelligence. A special thank you to Navitas Life Sciences for inviting us to share HALOPV and GRIP with the PV India community, and to everyone who stopped to talk to Louise and Praveen. It was great to connect and discuss the top challenges and priorities faced by the industry. #insife #thedrugsafetyexperts #GRIP #pvindia #regulatoryintelligence

Navitas Life Sciences is organizing the PV India Autumn Face-to-Face Forum on October 17, 2024, in Mumbai at the Hilton Mumbai Hotel. The theme for this year’s 17th PV India Autumn Forum is Navigating the Changing Regulatory and Technology Landscape. We’re excited to announce that representatives from Insife, including Louise Tan, Global Head of Regulatory Intelligence, and Praveen Gupta, Vice President of Digital Innovation, will be attending this prestigious event. Louise will be delivering a presentation on “The Global Regulatory Intelligence Club for Pharmacovigilance (GRIP)” at 12:00 PM, followed by an engaging discussion titled: “Regulatory Intelligence for PV – What Does Good Look Like?” We’re looking forward to an insightful exchange of ideas and perspectives on the future of regulatory intelligence! If you’re attending, don’t miss the chance to connect with Louise or Praveen to discuss the latest trends in regulatory intelligence and digital innovation in pharmacovigilance. Let’s connect, collaborate, and explore the future of pharmacovigilance together! #insife #thedrugsafetyexperts #GRIP #pvindia #regulatoryintelligence